Rank | Gene Set | Z-score |
---|---|---|
1 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.19343379 |
2 | proteasome assembly (GO:0043248) | 6.13525919 |
3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.73207405 |
4 | COPII vesicle coating (GO:0048208) | 5.30208011 |
5 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.25993919 |
6 | * positive regulation of nuclease activity (GO:0032075) | 5.07948762 |
7 | protein retention in ER lumen (GO:0006621) | 4.99489325 |
8 | vesicle coating (GO:0006901) | 4.84352005 |
9 | * regulation of nuclease activity (GO:0032069) | 4.67359041 |
10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.66986786 |
11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66986786 |
12 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 4.56050349 |
13 | signal peptide processing (GO:0006465) | 4.48268710 |
14 | * cellular response to unfolded protein (GO:0034620) | 4.40200392 |
15 | * ER-nucleus signaling pathway (GO:0006984) | 4.21590534 |
16 | * cellular response to topologically incorrect protein (GO:0035967) | 4.19383654 |
17 | cullin deneddylation (GO:0010388) | 4.18143009 |
18 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.12912986 |
19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12156618 |
20 | protein deneddylation (GO:0000338) | 4.11128420 |
21 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.05803161 |
22 | ribosome assembly (GO:0042255) | 4.05130987 |
23 | DNA double-strand break processing (GO:0000729) | 3.99618047 |
24 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.99333292 |
25 | protein maturation by protein folding (GO:0022417) | 3.93369781 |
26 | sequestering of metal ion (GO:0051238) | 3.92862623 |
27 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.92148176 |
28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.87773159 |
29 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.86008459 |
30 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.83298280 |
31 | macroautophagy (GO:0016236) | 3.83141349 |
32 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.78112191 |
33 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.78112191 |
34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.75218647 |
35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.75218647 |
36 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.75218647 |
37 | 4-hydroxyproline metabolic process (GO:0019471) | 3.74545417 |
38 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.70069592 |
39 | negative regulation of ligase activity (GO:0051352) | 3.70069592 |
40 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.68315195 |
41 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.64685997 |
42 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.64685997 |
43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.62934838 |
44 | * response to endoplasmic reticulum stress (GO:0034976) | 3.59514613 |
45 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.59004133 |
46 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.56114337 |
47 | tricarboxylic acid cycle (GO:0006099) | 3.50920321 |
48 | tricarboxylic acid metabolic process (GO:0072350) | 3.47860342 |
49 | regulation of translation in response to stress (GO:0043555) | 3.45770757 |
50 | * response to unfolded protein (GO:0006986) | 3.36714419 |
51 | positive regulation of ligase activity (GO:0051351) | 3.34912063 |
52 | valine metabolic process (GO:0006573) | 3.26777936 |
53 | * response to topologically incorrect protein (GO:0035966) | 3.25421405 |
54 | IMP biosynthetic process (GO:0006188) | 3.24653831 |
55 | mitochondrial DNA replication (GO:0006264) | 3.22802075 |
56 | Golgi organization (GO:0007030) | 3.21741325 |
57 | GDP-mannose metabolic process (GO:0019673) | 3.19721407 |
58 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.18941378 |
59 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.17525265 |
60 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.17309895 |
61 | mitochondrial RNA metabolic process (GO:0000959) | 3.15418280 |
62 | apoptotic cell clearance (GO:0043277) | 3.15032115 |
63 | low-density lipoprotein particle clearance (GO:0034383) | 3.14981209 |
64 | ER overload response (GO:0006983) | 3.14486688 |
65 | rRNA modification (GO:0000154) | 3.12882837 |
66 | tRNA aminoacylation for protein translation (GO:0006418) | 3.10837553 |
67 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.10599886 |
68 | endocrine pancreas development (GO:0031018) | 3.09567411 |
69 | proline biosynthetic process (GO:0006561) | 3.07740853 |
70 | peptidyl-asparagine modification (GO:0018196) | 3.07589313 |
71 | * ER to Golgi vesicle-mediated transport (GO:0006888) | 3.07081440 |
72 | amino acid activation (GO:0043038) | 3.04944686 |
73 | tRNA aminoacylation (GO:0043039) | 3.04944686 |
74 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.04647090 |
75 | regulation of ligase activity (GO:0051340) | 3.02646592 |
76 | peptide hormone processing (GO:0016486) | 2.99965485 |
77 | rRNA methylation (GO:0031167) | 2.99628969 |
78 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.97718934 |
79 | L-phenylalanine catabolic process (GO:0006559) | 2.97438573 |
80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97438573 |
81 | mitotic metaphase plate congression (GO:0007080) | 2.96773926 |
82 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.95790768 |
83 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.92842181 |
84 | peptidyl-histidine modification (GO:0018202) | 2.91275746 |
85 | establishment of viral latency (GO:0019043) | 2.90929561 |
86 | regulation of cellular amine metabolic process (GO:0033238) | 2.88045008 |
87 | chaperone-mediated protein transport (GO:0072321) | 2.86713919 |
88 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.86406293 |
89 | ventricular cardiac muscle cell development (GO:0055015) | 2.85803823 |
90 | positive regulation of cell cycle arrest (GO:0071158) | 2.85569660 |
91 | exocrine pancreas development (GO:0031017) | 2.84378776 |
92 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.83813934 |
93 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.82671621 |
94 | regulation of mitochondrial translation (GO:0070129) | 2.82595361 |
95 | L-phenylalanine metabolic process (GO:0006558) | 2.82515042 |
96 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82515042 |
97 | IMP metabolic process (GO:0046040) | 2.81718458 |
98 | tRNA methylation (GO:0030488) | 2.80968825 |
99 | growth hormone receptor signaling pathway (GO:0060396) | 2.80339927 |
100 | regulation of cholesterol homeostasis (GO:2000188) | 2.80291902 |
101 | protein targeting to mitochondrion (GO:0006626) | 2.80049062 |
102 | protein N-linked glycosylation (GO:0006487) | 2.79179495 |
103 | lysine metabolic process (GO:0006553) | 2.78790275 |
104 | lysine catabolic process (GO:0006554) | 2.78790275 |
105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78679550 |
106 | sexual reproduction (GO:0019953) | 2.77367215 |
107 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.77248862 |
108 | peptide catabolic process (GO:0043171) | 2.76275647 |
109 | mitochondrial DNA metabolic process (GO:0032042) | 2.75967421 |
110 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.73982246 |
111 | intestinal cholesterol absorption (GO:0030299) | 2.73947257 |
112 | metaphase plate congression (GO:0051310) | 2.70058258 |
113 | transcription from mitochondrial promoter (GO:0006390) | 2.69229574 |
114 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.68164791 |
115 | nucleotide-sugar metabolic process (GO:0009225) | 2.66996560 |
116 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.66872877 |
117 | type B pancreatic cell development (GO:0003323) | 2.65992651 |
118 | inner mitochondrial membrane organization (GO:0007007) | 2.65416951 |
119 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64816333 |
120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64788642 |
121 | lactate metabolic process (GO:0006089) | 2.63951488 |
122 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.63766126 |
123 | negative regulation of protein ubiquitination (GO:0031397) | 2.63654921 |
124 | respiratory chain complex IV assembly (GO:0008535) | 2.62427177 |
125 | 2-oxoglutarate metabolic process (GO:0006103) | 2.61632243 |
126 | negative regulation of fibrinolysis (GO:0051918) | 2.59815151 |
127 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.58592193 |
128 | oxaloacetate metabolic process (GO:0006107) | 2.58576158 |
129 | sulfur amino acid catabolic process (GO:0000098) | 2.58541101 |
130 | peptidyl-proline hydroxylation (GO:0019511) | 2.58515508 |
131 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.57643516 |
132 | protein carboxylation (GO:0018214) | 2.57643516 |
133 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.56599430 |
134 | positive regulation of glycolytic process (GO:0045821) | 2.55028897 |
135 | DNA replication checkpoint (GO:0000076) | 2.54286640 |
136 | cellular zinc ion homeostasis (GO:0006882) | 2.54170963 |
137 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.54144062 |
138 | positive regulation of histone deacetylation (GO:0031065) | 2.53487254 |
139 | establishment of integrated proviral latency (GO:0075713) | 2.53083676 |
140 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52986452 |
141 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.52278351 |
142 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.52278351 |
143 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.51616478 |
144 | signal transduction in response to DNA damage (GO:0042770) | 2.50771910 |
145 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.50596373 |
146 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.50539496 |
147 | cell cycle G1/S phase transition (GO:0044843) | 2.50539496 |
148 | cellular response to vitamin D (GO:0071305) | 2.50148880 |
149 | peroxisome fission (GO:0016559) | 2.49677302 |
150 | regulation of cholesterol storage (GO:0010885) | 2.49660005 |
151 | cellular response to growth hormone stimulus (GO:0071378) | 2.49237652 |
152 | nucleoside salvage (GO:0043174) | 2.48288728 |
153 | purine nucleobase biosynthetic process (GO:0009113) | 2.48022921 |
154 | pseudouridine synthesis (GO:0001522) | 2.47932966 |
155 | branched-chain amino acid catabolic process (GO:0009083) | 2.47596961 |
156 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.47455440 |
157 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.47305618 |
158 | protein localization to mitochondrion (GO:0070585) | 2.47118213 |
159 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.46516995 |
160 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.46418443 |
161 | formation of translation preinitiation complex (GO:0001731) | 2.44731501 |
162 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.44513066 |
163 | non-recombinational repair (GO:0000726) | 2.44513066 |
164 | regulation of metalloenzyme activity (GO:0048552) | 2.43051590 |
165 | * Golgi vesicle transport (GO:0048193) | 2.42734536 |
166 | establishment of protein localization to mitochondrion (GO:0072655) | 2.41670348 |
167 | regulation of cofactor metabolic process (GO:0051193) | 2.41523354 |
168 | intestinal absorption (GO:0050892) | 2.40279509 |
169 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40226742 |
170 | cellular response to nutrient (GO:0031670) | 2.39181973 |
171 | keratan sulfate catabolic process (GO:0042340) | 2.39093985 |
172 | plasma lipoprotein particle clearance (GO:0034381) | 2.33696235 |
173 | cellular response to vitamin (GO:0071295) | 2.33034169 |
174 | localization within membrane (GO:0051668) | 2.32352542 |
175 | stress fiber assembly (GO:0043149) | 2.29458862 |
176 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.29054980 |
177 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.29054980 |
178 | transcytosis (GO:0045056) | 2.27988166 |
179 | pentose-phosphate shunt (GO:0006098) | 2.25358194 |
180 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25267260 |
181 | NADPH regeneration (GO:0006740) | 2.24898836 |
182 | glyoxylate metabolic process (GO:0046487) | 2.22924780 |
183 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.21940992 |
184 | negative regulation of lipid transport (GO:0032369) | 2.17993298 |
185 | complement activation, alternative pathway (GO:0006957) | 2.17524543 |
186 | cell redox homeostasis (GO:0045454) | 2.17241294 |
187 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.15128754 |
188 | negative regulation of bone resorption (GO:0045779) | 2.14812805 |
189 | Golgi transport vesicle coating (GO:0048200) | 10.4084764 |
190 | COPI coating of Golgi vesicle (GO:0048205) | 10.4084764 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.25798046 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.65876955 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.49104036 |
4 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.10164648 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.85214035 |
6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.64077423 |
7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.52679010 |
8 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.43271982 |
9 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.32340550 |
10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.24547260 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20977727 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17842853 |
13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.16329626 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03610138 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03439680 |
16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.02494100 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.01331745 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.92574251 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.81182613 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74919167 |
21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.66901133 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.54516889 |
23 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.53795359 |
24 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.52253360 |
25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.51669518 |
26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.51402362 |
27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.40200492 |
28 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.34168756 |
29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.33460954 |
30 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.29720771 |
31 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.24855658 |
32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23062431 |
33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.21085420 |
34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.18706211 |
35 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.14461795 |
36 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.13513583 |
37 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.13409336 |
38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.13373285 |
39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.08782808 |
40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05325580 |
41 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.05157765 |
42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.03518078 |
43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98932692 |
44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.97785719 |
45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.96798745 |
46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96642267 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95561634 |
48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.93989027 |
49 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.92036758 |
50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91181489 |
51 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.85271901 |
52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83386179 |
53 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.82185562 |
54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79602821 |
55 | MYC_22102868_ChIP-Seq_BL_Human | 1.77508919 |
56 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.77284844 |
57 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76902478 |
58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.71383058 |
59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70622798 |
60 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.68362812 |
61 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68302384 |
62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68058871 |
63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66565085 |
64 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.66505055 |
65 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.59800893 |
66 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59647483 |
67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.58981190 |
68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56732713 |
69 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.56059871 |
70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54029454 |
71 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52543849 |
72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51723213 |
73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51219964 |
74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49424993 |
75 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48709871 |
76 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48691417 |
77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46706036 |
78 | MYB_26560356_Chip-Seq_TH2_Human | 1.46086293 |
79 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.40727584 |
80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.40295031 |
81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39509792 |
82 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38271753 |
83 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38148167 |
84 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37783735 |
85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37433562 |
86 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37217666 |
87 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35564103 |
88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35117530 |
89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35106975 |
90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34986152 |
91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34669075 |
92 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34095273 |
93 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.34024339 |
94 | MAF_26560356_Chip-Seq_TH1_Human | 1.33474030 |
95 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.32494252 |
96 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.32392825 |
97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30437651 |
98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29678073 |
99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29047605 |
100 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28295411 |
101 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27614487 |
102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27123823 |
103 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26512019 |
104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25913363 |
105 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25912742 |
106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25848621 |
107 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25243831 |
108 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.24651411 |
109 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.23624513 |
110 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23540808 |
111 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22351491 |
112 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21514895 |
113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20178219 |
114 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19080656 |
115 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18949290 |
116 | MYB_26560356_Chip-Seq_TH1_Human | 1.18612267 |
117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17156303 |
118 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16519504 |
119 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15200023 |
120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14154047 |
121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11939707 |
122 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11498215 |
123 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11088249 |
124 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09469294 |
125 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09407708 |
126 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.09353916 |
127 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08927483 |
128 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08024193 |
129 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07484369 |
130 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07113616 |
131 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.06715760 |
132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05779285 |
133 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05163245 |
134 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04832471 |
135 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03995815 |
136 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03482519 |
137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02652111 |
138 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02133330 |
139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02040279 |
140 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01934828 |
141 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01914768 |
142 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01884601 |
143 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01852650 |
144 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01671058 |
145 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00647237 |
146 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.00333342 |
147 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00333264 |
148 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99979045 |
149 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99943628 |
150 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99828969 |
151 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98511261 |
152 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98444166 |
153 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97818523 |
154 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.97210269 |
155 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96981517 |
156 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96539403 |
157 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96020667 |
158 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95775905 |
159 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95749735 |
160 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95749735 |
161 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95730995 |
162 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95287320 |
163 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95203800 |
164 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94966641 |
165 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92866722 |
166 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91092686 |
167 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90700975 |
168 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89632536 |
169 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89512326 |
170 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89090522 |
171 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88530288 |
172 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88525681 |
173 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.87887913 |
174 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83960909 |
175 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.82782551 |
176 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82066555 |
177 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80433789 |
178 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.78803515 |
179 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78351271 |
180 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78307163 |
181 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78078008 |
182 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76757970 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 3.21633637 |
2 | MP0002877_abnormal_melanocyte_morpholog | 3.12310620 |
3 | MP0009697_abnormal_copulation | 2.99552253 |
4 | MP0009840_abnormal_foam_cell | 2.89843640 |
5 | MP0003300_gastrointestinal_ulcer | 2.85693310 |
6 | MP0008058_abnormal_DNA_repair | 2.82846835 |
7 | MP0005058_abnormal_lysosome_morphology | 2.76907514 |
8 | MP0004957_abnormal_blastocyst_morpholog | 2.74687645 |
9 | MP0003705_abnormal_hypodermis_morpholog | 2.73629462 |
10 | MP0008438_abnormal_cutaneous_collagen | 2.72070831 |
11 | MP0003786_premature_aging | 2.64149595 |
12 | MP0000013_abnormal_adipose_tissue | 2.61083556 |
13 | MP0006054_spinal_hemorrhage | 2.52759107 |
14 | MP0003186_abnormal_redox_activity | 2.52390429 |
15 | MP0003195_calcinosis | 2.49943679 |
16 | MP0005360_urolithiasis | 2.44437037 |
17 | MP0005365_abnormal_bile_salt | 2.43628946 |
18 | MP0009780_abnormal_chondrocyte_physiolo | 2.36676749 |
19 | MP0010094_abnormal_chromosome_stability | 2.33386179 |
20 | MP0004272_abnormal_basement_membrane | 2.30791225 |
21 | MP0003718_maternal_effect | 2.21094814 |
22 | MP0008260_abnormal_autophagy | 2.18623569 |
23 | MP0002909_abnormal_adrenal_gland | 2.12982176 |
24 | MP0008932_abnormal_embryonic_tissue | 2.12545205 |
25 | MP0005451_abnormal_body_composition | 2.10628921 |
26 | MP0003693_abnormal_embryo_hatching | 2.09118006 |
27 | MP0003183_abnormal_peptide_metabolism | 2.07619854 |
28 | MP0003111_abnormal_nucleus_morphology | 2.06909365 |
29 | MP0003172_abnormal_lysosome_physiology | 2.01290788 |
30 | MP0003077_abnormal_cell_cycle | 2.00449734 |
31 | MP0003950_abnormal_plasma_membrane | 2.00163477 |
32 | MP0002693_abnormal_pancreas_physiology | 1.91289566 |
33 | MP0004043_abnormal_pH_regulation | 1.89718826 |
34 | MP0001666_abnormal_nutrient_absorption | 1.87462473 |
35 | MP0003252_abnormal_bile_duct | 1.87070074 |
36 | MP0003191_abnormal_cellular_cholesterol | 1.86542025 |
37 | MP0008007_abnormal_cellular_replicative | 1.84556795 |
38 | MP0010386_abnormal_urinary_bladder | 1.81663251 |
39 | MP0008057_abnormal_DNA_replication | 1.80066242 |
40 | MP0003303_peritoneal_inflammation | 1.74557209 |
41 | MP0001944_abnormal_pancreas_morphology | 1.73767354 |
42 | MP0005220_abnormal_exocrine_pancreas | 1.72539157 |
43 | MP0003436_decreased_susceptibility_to | 1.70852373 |
44 | MP0005085_abnormal_gallbladder_physiolo | 1.68592802 |
45 | MP0010329_abnormal_lipoprotein_level | 1.60241718 |
46 | MP0000358_abnormal_cell_content/ | 1.59502769 |
47 | MP0001730_embryonic_growth_arrest | 1.55807505 |
48 | MP0009643_abnormal_urine_homeostasis | 1.55284507 |
49 | MP0000609_abnormal_liver_physiology | 1.52913166 |
50 | MP0006036_abnormal_mitochondrial_physio | 1.51900741 |
51 | MP0001764_abnormal_homeostasis | 1.50820513 |
52 | MP0008961_abnormal_basal_metabolism | 1.49026679 |
53 | MP0002138_abnormal_hepatobiliary_system | 1.47344002 |
54 | MP0003283_abnormal_digestive_organ | 1.46301509 |
55 | MP0006035_abnormal_mitochondrial_morpho | 1.41357521 |
56 | MP0000685_abnormal_immune_system | 1.38273192 |
57 | MP0002078_abnormal_glucose_homeostasis | 1.36971850 |
58 | MP0001533_abnormal_skeleton_physiology | 1.35270218 |
59 | MP0001835_abnormal_antigen_presentation | 1.32103377 |
60 | MP0010352_gastrointestinal_tract_polyps | 1.31422899 |
61 | MP0005083_abnormal_biliary_tract | 1.28944933 |
62 | MP0004130_abnormal_muscle_cell | 1.28726721 |
63 | MP0008995_early_reproductive_senescence | 1.28220207 |
64 | MP0003941_abnormal_skin_development | 1.27167560 |
65 | MP0000604_amyloidosis | 1.24967757 |
66 | MP0000372_irregular_coat_pigmentation | 1.24314100 |
67 | MP0002118_abnormal_lipid_homeostasis | 1.21135684 |
68 | MP0004264_abnormal_extraembryonic_tissu | 1.20683600 |
69 | MP0003566_abnormal_cell_adhesion | 1.20509427 |
70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20064103 |
71 | MP0004947_skin_inflammation | 1.19813693 |
72 | MP0000003_abnormal_adipose_tissue | 1.18780588 |
73 | MP0000538_abnormal_urinary_bladder | 1.17757618 |
74 | MP0002896_abnormal_bone_mineralization | 1.17607354 |
75 | MP0001756_abnormal_urination | 1.17011553 |
76 | MP0005395_other_phenotype | 1.15724848 |
77 | MP0008789_abnormal_olfactory_epithelium | 1.15069511 |
78 | MP0005367_renal/urinary_system_phenotyp | 1.15042622 |
79 | MP0000516_abnormal_urinary_system | 1.15042622 |
80 | MP0003279_aneurysm | 1.14947299 |
81 | MP0003656_abnormal_erythrocyte_physiolo | 1.13432148 |
82 | MP0005076_abnormal_cell_differentiation | 1.11980547 |
83 | MP0005275_abnormal_skin_tensile | 1.11702761 |
84 | MP0003806_abnormal_nucleotide_metabolis | 1.10447354 |
85 | MP0002419_abnormal_innate_immunity | 1.10057354 |
86 | MP0005000_abnormal_immune_tolerance | 1.08979530 |
87 | MP0004233_abnormal_muscle_weight | 1.08780423 |
88 | MP0001727_abnormal_embryo_implantation | 1.08046361 |
89 | MP0002332_abnormal_exercise_endurance | 1.06500582 |
90 | MP0005464_abnormal_platelet_physiology | 1.06291331 |
91 | MP0002080_prenatal_lethality | 1.05549754 |
92 | MP0002102_abnormal_ear_morphology | 1.05259349 |
93 | MP0002166_altered_tumor_susceptibility | 1.05213189 |
94 | MP0005332_abnormal_amino_acid | 1.04766437 |
95 | MP0005408_hypopigmentation | 1.04729368 |
96 | MP0005623_abnormal_meninges_morphology | 1.04712372 |
97 | MP0004147_increased_porphyrin_level | 1.04211210 |
98 | MP0001672_abnormal_embryogenesis/_devel | 1.03598499 |
99 | MP0005380_embryogenesis_phenotype | 1.03598499 |
100 | MP0010368_abnormal_lymphatic_system | 1.03482880 |
101 | MP0001845_abnormal_inflammatory_respons | 1.02576237 |
102 | MP0000749_muscle_degeneration | 1.02554236 |
103 | MP0001697_abnormal_embryo_size | 1.02198137 |
104 | MP0000598_abnormal_liver_morphology | 1.02180400 |
105 | MP0005319_abnormal_enzyme/_coenzyme | 1.01550475 |
106 | MP0008469_abnormal_protein_level | 1.00311544 |
107 | MP0003984_embryonic_growth_retardation | 0.98674991 |
108 | MP0005023_abnormal_wound_healing | 0.98626895 |
109 | MP0001529_abnormal_vocalization | 0.97588755 |
110 | MP0005387_immune_system_phenotype | 0.97100105 |
111 | MP0001790_abnormal_immune_system | 0.97100105 |
112 | MP0002295_abnormal_pulmonary_circulatio | 0.95740086 |
113 | MP0005384_cellular_phenotype | 0.95597341 |
114 | MP0000350_abnormal_cell_proliferation | 0.95259542 |
115 | MP0001542_abnormal_bone_strength | 0.95241045 |
116 | MP0005621_abnormal_cell_physiology | 0.93498681 |
117 | MP0002088_abnormal_embryonic_growth/wei | 0.93237523 |
118 | MP0006082_CNS_inflammation | 0.92750182 |
119 | MP0005266_abnormal_metabolism | 0.91924352 |
120 | MP0005330_cardiomyopathy | 0.91767366 |
121 | MP0001958_emphysema | 0.91196262 |
122 | MP0003868_abnormal_feces_composition | 0.90002350 |
123 | MP0002933_joint_inflammation | 0.88620426 |
124 | MP0001243_abnormal_dermal_layer | 0.87590326 |
125 | MP0001765_abnormal_ion_homeostasis | 0.87199552 |
126 | MP0003795_abnormal_bone_structure | 0.87193246 |
127 | MP0001661_extended_life_span | 0.86781454 |
128 | MP0002269_muscular_atrophy | 0.86381325 |
129 | MP0002086_abnormal_extraembryonic_tissu | 0.86135612 |
130 | MP0003724_increased_susceptibility_to | 0.86123474 |
131 | MP0002998_abnormal_bone_remodeling | 0.85670506 |
132 | MP0002060_abnormal_skin_morphology | 0.84970738 |
133 | MP0004215_abnormal_myocardial_fiber | 0.84435791 |
134 | MP0005671_abnormal_response_to | 0.83720596 |
135 | MP0010234_abnormal_vibrissa_follicle | 0.82411646 |
136 | MP0003091_abnormal_cell_migration | 0.81577471 |
137 | MP0005375_adipose_tissue_phenotype | 0.81489874 |
138 | MP0002928_abnormal_bile_duct | 0.81484520 |
139 | MP0005025_abnormal_response_to | 0.80241301 |
140 | MP0004185_abnormal_adipocyte_glucose | 0.79742087 |
141 | MP0009785_altered_susceptibility_to | 0.79474287 |
142 | MP0009384_cardiac_valve_regurgitation | 0.79055442 |
143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.78708488 |
144 | MP0005636_abnormal_mineral_homeostasis | 0.78235107 |
145 | MP0005310_abnormal_salivary_gland | 0.77448495 |
146 | MP0005376_homeostasis/metabolism_phenot | 0.77444743 |
147 | MP0002723_abnormal_immune_serum | 0.77402328 |
148 | MP0002084_abnormal_developmental_patter | 0.77345829 |
149 | MP0005379_endocrine/exocrine_gland_phen | 0.76758841 |
150 | MP0002452_abnormal_antigen_presenting | 0.76070309 |
151 | MP0005670_abnormal_white_adipose | 0.75386486 |
152 | MP0001915_intracranial_hemorrhage | 0.75124123 |
153 | MP0000313_abnormal_cell_death | 0.74983055 |
154 | MP0009642_abnormal_blood_homeostasis | 0.74325402 |
155 | MP0003959_abnormal_lean_body | 0.73938806 |
156 | MP0003075_altered_response_to | 0.73522250 |
157 | MP0010307_abnormal_tumor_latency | 0.73258571 |
158 | MP0001929_abnormal_gametogenesis | 0.72790961 |
159 | MP0002132_abnormal_respiratory_system | 0.72086671 |
160 | MP0002420_abnormal_adaptive_immunity | 0.71957925 |
161 | MP0001819_abnormal_immune_cell | 0.71629199 |
162 | MP0005197_abnormal_uvea_morphology | 0.70409666 |
163 | MP0005084_abnormal_gallbladder_morpholo | 0.69896144 |
164 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69826276 |
165 | MP0002837_dystrophic_cardiac_calcinosis | 0.69456424 |
166 | MP0010030_abnormal_orbit_morphology | 0.67601131 |
167 | MP0005410_abnormal_fertilization | 0.67248968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 4.16877659 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.72183349 |
3 | Abnormality of glycolysis (HP:0004366) | 3.65078482 |
4 | Increased serum pyruvate (HP:0003542) | 3.54789939 |
5 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.51773223 |
6 | Mucopolysacchariduria (HP:0008155) | 3.51773223 |
7 | Hypoglycemic seizures (HP:0002173) | 3.42679455 |
8 | Abnormal gallbladder physiology (HP:0012438) | 3.41273817 |
9 | Cholecystitis (HP:0001082) | 3.41273817 |
10 | Type I transferrin isoform profile (HP:0003642) | 3.23679783 |
11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.18176479 |
12 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.18176479 |
13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.18176479 |
14 | Dysostosis multiplex (HP:0000943) | 3.17526646 |
15 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.08229321 |
16 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.08229321 |
17 | Abnormal protein glycosylation (HP:0012346) | 3.08229321 |
18 | Abnormal glycosylation (HP:0012345) | 3.08229321 |
19 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07132089 |
20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.06668786 |
21 | Increased cerebral lipofuscin (HP:0011813) | 3.00157031 |
22 | Ketoacidosis (HP:0001993) | 2.97102824 |
23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.95721579 |
24 | Deep venous thrombosis (HP:0002625) | 2.92883681 |
25 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.92863993 |
26 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.92863993 |
27 | Entropion (HP:0000621) | 2.91354078 |
28 | Reduced antithrombin III activity (HP:0001976) | 2.88150959 |
29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84604982 |
30 | Cerebral aneurysm (HP:0004944) | 2.84482263 |
31 | Secondary amenorrhea (HP:0000869) | 2.81602567 |
32 | Microvesicular hepatic steatosis (HP:0001414) | 2.76676528 |
33 | Acute encephalopathy (HP:0006846) | 2.75050485 |
34 | Late onset (HP:0003584) | 2.69526173 |
35 | Hepatic necrosis (HP:0002605) | 2.69357801 |
36 | Xanthomatosis (HP:0000991) | 2.66231408 |
37 | Hyperglycemia (HP:0003074) | 2.65622864 |
38 | Premature ovarian failure (HP:0008209) | 2.62477052 |
39 | Hepatocellular necrosis (HP:0001404) | 2.61785830 |
40 | Abnormality of methionine metabolism (HP:0010901) | 2.57466201 |
41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.56441218 |
42 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.55749784 |
43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54352144 |
44 | Acute necrotizing encephalopathy (HP:0006965) | 2.53577396 |
45 | Ketosis (HP:0001946) | 2.52647379 |
46 | Increased CSF lactate (HP:0002490) | 2.51579599 |
47 | Peritonitis (HP:0002586) | 2.46558384 |
48 | Symptomatic seizures (HP:0011145) | 2.46383665 |
49 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.46146035 |
50 | Single umbilical artery (HP:0001195) | 2.46146035 |
51 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.46146035 |
52 | Protrusio acetabuli (HP:0003179) | 2.42646133 |
53 | Increased serum lactate (HP:0002151) | 2.41768914 |
54 | Cerebral hypomyelination (HP:0006808) | 2.36151164 |
55 | Nonimmune hydrops fetalis (HP:0001790) | 2.32883292 |
56 | Premature rupture of membranes (HP:0001788) | 2.31716279 |
57 | Abnormality of the umbilical cord (HP:0010881) | 2.30091135 |
58 | Proximal tubulopathy (HP:0000114) | 2.29725429 |
59 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.28668117 |
60 | Progressive macrocephaly (HP:0004481) | 2.28434502 |
61 | Complement deficiency (HP:0004431) | 2.27350561 |
62 | Hand muscle atrophy (HP:0009130) | 2.27340930 |
63 | Lactic acidosis (HP:0003128) | 2.26429114 |
64 | Long toe (HP:0010511) | 2.25882662 |
65 | Papilledema (HP:0001085) | 2.25734630 |
66 | Mitral stenosis (HP:0001718) | 2.25489709 |
67 | Rough bone trabeculation (HP:0100670) | 2.23659233 |
68 | Abnormality of the anterior horn cell (HP:0006802) | 2.22891712 |
69 | Degeneration of anterior horn cells (HP:0002398) | 2.22891712 |
70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21458791 |
71 | Generalized aminoaciduria (HP:0002909) | 2.20799999 |
72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20121021 |
73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17887983 |
74 | Cerebral edema (HP:0002181) | 2.17500440 |
75 | Metaphyseal cupping (HP:0003021) | 2.16266375 |
76 | Upper limb muscle weakness (HP:0003484) | 2.16130430 |
77 | Postnatal microcephaly (HP:0005484) | 2.15454624 |
78 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.14886465 |
79 | Mitochondrial inheritance (HP:0001427) | 2.14573053 |
80 | Cholelithiasis (HP:0001081) | 2.14286914 |
81 | Asymmetric septal hypertrophy (HP:0001670) | 2.14123365 |
82 | Hypobetalipoproteinemia (HP:0003563) | 2.13249326 |
83 | Polycythemia (HP:0001901) | 2.13005186 |
84 | Cervical subluxation (HP:0003308) | 2.12706393 |
85 | Orthostatic hypotension (HP:0001278) | 2.11499090 |
86 | Intrahepatic cholestasis (HP:0001406) | 2.11345852 |
87 | Abnormality of the nasal mucosa (HP:0000433) | 2.10719256 |
88 | Ependymoma (HP:0002888) | 2.09702245 |
89 | CNS demyelination (HP:0007305) | 2.09511280 |
90 | Nasal polyposis (HP:0100582) | 2.08090616 |
91 | Systemic lupus erythematosus (HP:0002725) | 2.07135871 |
92 | Eczematoid dermatitis (HP:0000976) | 2.07111985 |
93 | Gout (HP:0001997) | 2.06779431 |
94 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.05386145 |
95 | Global brain atrophy (HP:0002283) | 2.03926722 |
96 | Hypokinesia (HP:0002375) | 2.03352065 |
97 | Hematochezia (HP:0002573) | 2.02525791 |
98 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.02462535 |
99 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.02345202 |
100 | Abnormality of purine metabolism (HP:0004352) | 2.02163148 |
101 | Large for gestational age (HP:0001520) | 2.00918977 |
102 | Retinal atrophy (HP:0001105) | 2.00455898 |
103 | Upper limb amyotrophy (HP:0009129) | 2.00143087 |
104 | Distal upper limb amyotrophy (HP:0007149) | 2.00143087 |
105 | Skin nodule (HP:0200036) | 2.00010391 |
106 | Aneurysm (HP:0002617) | 1.99023369 |
107 | Interstitial pulmonary disease (HP:0006530) | 1.97481436 |
108 | Thoracolumbar scoliosis (HP:0002944) | 1.97443852 |
109 | Renal Fanconi syndrome (HP:0001994) | 1.96203243 |
110 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96138735 |
111 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96138735 |
112 | Autoimmune thrombocytopenia (HP:0001973) | 1.95855640 |
113 | Dicarboxylic aciduria (HP:0003215) | 1.94065897 |
114 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94065897 |
115 | Vacuolated lymphocytes (HP:0001922) | 1.93152527 |
116 | Slender build (HP:0001533) | 1.92578443 |
117 | Insulin resistance (HP:0000855) | 1.91639621 |
118 | Exercise intolerance (HP:0003546) | 1.90595520 |
119 | Cutaneous melanoma (HP:0012056) | 1.89923971 |
120 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88999305 |
121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88690080 |
122 | Dilatation of the ascending aorta (HP:0005111) | 1.87589714 |
123 | Abnormality of the metopic suture (HP:0005556) | 1.87410349 |
124 | Hypothermia (HP:0002045) | 1.87301792 |
125 | Protuberant abdomen (HP:0001538) | 1.87244586 |
126 | Striae distensae (HP:0001065) | 1.84924051 |
127 | Vertebral compression fractures (HP:0002953) | 1.83751293 |
128 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.83306417 |
129 | Resting tremor (HP:0002322) | 1.83020551 |
130 | Thrombocytosis (HP:0001894) | 1.82762707 |
131 | CNS hypomyelination (HP:0003429) | 1.80457866 |
132 | Respiratory failure (HP:0002878) | 1.79600703 |
133 | Abnormal trabecular bone morphology (HP:0100671) | 1.79486920 |
134 | Hyperammonemia (HP:0001987) | 1.79199518 |
135 | Myocardial infarction (HP:0001658) | 1.79157663 |
136 | Autoamputation (HP:0001218) | 1.79098292 |
137 | Nausea (HP:0002018) | 1.78499501 |
138 | Exertional dyspnea (HP:0002875) | 1.77990331 |
139 | Thin bony cortex (HP:0002753) | 1.77890364 |
140 | Fatigue (HP:0012378) | 1.77849304 |
141 | Shoulder girdle muscle weakness (HP:0003547) | 1.77196854 |
142 | Glucose intolerance (HP:0000833) | 1.76580299 |
143 | Increased CSF protein (HP:0002922) | 1.76428006 |
144 | Lethargy (HP:0001254) | 1.75243499 |
145 | Hypoalphalipoproteinemia (HP:0003233) | 1.74754814 |
146 | Prominent metopic ridge (HP:0005487) | 1.73566451 |
147 | Aortic aneurysm (HP:0004942) | 1.72638861 |
148 | Opisthotonus (HP:0002179) | 1.72366375 |
149 | Chromsome breakage (HP:0040012) | 1.71718355 |
150 | Osteolytic defects of the hand bones (HP:0009699) | 1.71688944 |
151 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71688944 |
152 | Severe short stature (HP:0003510) | 1.71428242 |
153 | Loss of speech (HP:0002371) | 1.71267760 |
154 | Tongue fasciculations (HP:0001308) | 1.71249873 |
155 | Sensorimotor neuropathy (HP:0007141) | 1.71122989 |
156 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.70285531 |
157 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.69474072 |
158 | Abnormality of glycolipid metabolism (HP:0010969) | 1.69474072 |
159 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.69474072 |
160 | Fat malabsorption (HP:0002630) | 1.69199825 |
161 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.68699676 |
162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68409349 |
163 | Hypoplastic left heart (HP:0004383) | 1.67666830 |
164 | Hepatocellular carcinoma (HP:0001402) | 1.67259351 |
165 | Subacute progressive viral hepatitis (HP:0006572) | 1.65786238 |
166 | Myoglobinuria (HP:0002913) | 1.65358345 |
167 | Patchy hypopigmentation of hair (HP:0011365) | 1.65172295 |
168 | Abnormality of dentin (HP:0010299) | 1.65036704 |
169 | Cortical dysplasia (HP:0002539) | 1.64743898 |
170 | Glycosuria (HP:0003076) | 1.64686753 |
171 | Abnormality of urine glucose concentration (HP:0011016) | 1.64686753 |
172 | Abnormality of nucleobase metabolism (HP:0010932) | 1.64671317 |
173 | Hypolipoproteinemia (HP:0010981) | 1.64181861 |
174 | Mucosal telangiectasiae (HP:0100579) | 1.63349175 |
175 | Ovoid vertebral bodies (HP:0003300) | 1.63023604 |
176 | Aortic dissection (HP:0002647) | 1.62039923 |
177 | Cardiomegaly (HP:0001640) | 1.61393142 |
178 | Abnormal cartilage morphology (HP:0002763) | 1.60239114 |
179 | Spontaneous hematomas (HP:0007420) | 1.59226567 |
180 | Abnormality of complement system (HP:0005339) | 1.58181557 |
181 | Abnormal gallbladder morphology (HP:0012437) | 1.57936656 |
182 | Elevated alkaline phosphatase (HP:0003155) | 1.57157373 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK3 | 4.64006497 |
2 | TRIB3 | 4.60900105 |
3 | ERN1 | 4.28388854 |
4 | EIF2AK1 | 4.27012646 |
5 | PBK | 3.39686266 |
6 | STK16 | 3.16798010 |
7 | PASK | 3.06510653 |
8 | MST4 | 2.96209750 |
9 | SRPK1 | 2.84221034 |
10 | PKN2 | 2.80895324 |
11 | PRKD3 | 2.72601500 |
12 | FLT3 | 2.67639910 |
13 | TRIM28 | 2.60420842 |
14 | SCYL2 | 2.49044531 |
15 | TAOK3 | 2.45551349 |
16 | BUB1 | 2.43093303 |
17 | MYLK | 2.35652022 |
18 | ERBB3 | 2.29352195 |
19 | TESK1 | 2.29166693 |
20 | MAP4K2 | 2.07965346 |
21 | MAP3K12 | 1.92439994 |
22 | LRRK2 | 1.90716277 |
23 | PTK6 | 1.89228701 |
24 | MAP3K2 | 1.88688351 |
25 | ZAP70 | 1.88396361 |
26 | EEF2K | 1.77812185 |
27 | PDGFRA | 1.77107234 |
28 | NME2 | 1.75154475 |
29 | TBK1 | 1.74222451 |
30 | TTK | 1.72155540 |
31 | NME1 | 1.71940356 |
32 | PIM2 | 1.71673318 |
33 | MAP4K1 | 1.68421333 |
34 | FGFR4 | 1.68014407 |
35 | TSSK6 | 1.67461007 |
36 | RIPK1 | 1.59896953 |
37 | MAP3K10 | 1.59857323 |
38 | NEK9 | 1.54905533 |
39 | BCKDK | 1.54044127 |
40 | TYK2 | 1.50278938 |
41 | JAK3 | 1.48893301 |
42 | JAK1 | 1.46337940 |
43 | PLK4 | 1.45843765 |
44 | INSRR | 1.44272018 |
45 | SIK3 | 1.38634953 |
46 | PLK3 | 1.37983561 |
47 | SIK1 | 1.37530375 |
48 | ERBB4 | 1.35797833 |
49 | EPHB1 | 1.35619025 |
50 | TTN | 1.33849238 |
51 | ZAK | 1.30481106 |
52 | KIT | 1.29589831 |
53 | MST1R | 1.24714681 |
54 | VRK2 | 1.22185353 |
55 | TESK2 | 1.21414918 |
56 | KSR2 | 1.20189457 |
57 | PDK4 | 1.19361569 |
58 | PDK3 | 1.19361569 |
59 | RET | 1.18993827 |
60 | BMPR1B | 1.16103917 |
61 | PTK2 | 1.15785499 |
62 | STK10 | 1.14855406 |
63 | WEE1 | 1.12121533 |
64 | AKT3 | 1.11277128 |
65 | MAP2K3 | 1.10854759 |
66 | BCR | 1.10647914 |
67 | PRKCH | 1.09687254 |
68 | PLK2 | 1.09500435 |
69 | EPHA3 | 1.09397370 |
70 | JAK2 | 1.06642179 |
71 | NTRK1 | 1.05578081 |
72 | KDR | 1.05434777 |
73 | MET | 1.04692999 |
74 | IRAK3 | 0.98421757 |
75 | TGFBR2 | 0.97948542 |
76 | MAP3K3 | 0.96838179 |
77 | CSNK1G1 | 0.93006035 |
78 | BRSK2 | 0.92821784 |
79 | PLK1 | 0.92348334 |
80 | CSF1R | 0.92263585 |
81 | PAK3 | 0.90893862 |
82 | HIPK2 | 0.90230310 |
83 | TGFBR1 | 0.90097451 |
84 | MAP3K1 | 0.87348399 |
85 | CLK1 | 0.86463470 |
86 | CSNK1G3 | 0.85460073 |
87 | PAK4 | 0.83004132 |
88 | IRAK4 | 0.81989059 |
89 | LMTK2 | 0.80137098 |
90 | EIF2AK2 | 0.79045038 |
91 | RAF1 | 0.78023578 |
92 | ITK | 0.74929664 |
93 | CAMKK1 | 0.74309621 |
94 | PDGFRB | 0.73847107 |
95 | CAMKK2 | 0.73537527 |
96 | ACVR1B | 0.73508643 |
97 | TNIK | 0.72155714 |
98 | CSNK1A1L | 0.72014132 |
99 | FER | 0.70818081 |
100 | DAPK3 | 0.69625543 |
101 | DYRK1B | 0.69377391 |
102 | BRD4 | 0.68661555 |
103 | NUAK1 | 0.65006951 |
104 | DAPK1 | 0.64630283 |
105 | RPS6KA4 | 0.64326687 |
106 | CSK | 0.63603636 |
107 | LIMK1 | 0.63470487 |
108 | ATR | 0.62428746 |
109 | WNK4 | 0.62032827 |
110 | CCNB1 | 0.61585070 |
111 | AURKA | 0.60115854 |
112 | NLK | 0.58576005 |
113 | MAPK15 | 0.58531752 |
114 | CDK8 | 0.58428240 |
115 | ALK | 0.58378773 |
116 | BMPR2 | 0.57703783 |
117 | FRK | 0.57432236 |
118 | PAK2 | 0.57144893 |
119 | CAMK1D | 0.56132860 |
120 | CDC7 | 0.55995453 |
121 | AURKB | 0.55383466 |
122 | STK3 | 0.55071267 |
123 | VRK1 | 0.53686840 |
124 | CDK9 | 0.53376275 |
125 | PAK1 | 0.52942781 |
126 | SYK | 0.52655285 |
127 | IRAK1 | 0.51127283 |
128 | MTOR | 0.50586047 |
129 | STK4 | 0.48858212 |
130 | EPHA2 | 0.48153009 |
131 | PIK3CG | 0.47289336 |
132 | PDPK1 | 0.46860518 |
133 | MAP3K14 | 0.46696715 |
134 | PDK1 | 0.46584454 |
135 | PRKG2 | 0.46384375 |
136 | CHEK1 | 0.45325481 |
137 | CSNK1G2 | 0.45065765 |
138 | MAP2K2 | 0.44604586 |
139 | ATM | 0.44510060 |
140 | MAP3K8 | 0.44166364 |
141 | FGFR3 | 0.43595408 |
142 | GRK6 | 0.43545003 |
143 | MAPKAPK3 | 0.43421607 |
144 | BMX | 0.42564229 |
145 | TRPM7 | 0.41789603 |
146 | ABL2 | 0.41784276 |
147 | CDK7 | 0.41756530 |
148 | ILK | 0.41576202 |
149 | MAPK11 | 0.41186910 |
150 | AKT2 | 0.40855747 |
151 | DDR2 | 0.40671863 |
152 | CSNK2A1 | 0.39415837 |
153 | IGF1R | 0.38962259 |
154 | PRKCE | 0.38659767 |
155 | BRSK1 | 0.38216023 |
156 | IKBKE | 0.37844668 |
157 | MARK3 | 0.37789316 |
158 | TAOK1 | 0.37492499 |
159 | PDK2 | 0.36767733 |
160 | EGFR | 0.36580634 |
161 | LATS1 | 0.36119972 |
162 | MAP2K1 | 0.35062804 |
163 | MAP3K5 | 0.35018233 |
164 | CSNK2A2 | 0.34406834 |
165 | MAP2K7 | 0.34100770 |
166 | NEK1 | 0.33744603 |
167 | MUSK | 0.32832452 |
168 | ROCK1 | 0.32272251 |
169 | LCK | 0.32267148 |
170 | CHEK2 | 0.31887643 |
171 | FGFR1 | 0.31249825 |
172 | ICK | 0.30643631 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.66812761 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.44264350 |
3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.12598255 |
4 | Protein export_Homo sapiens_hsa03060 | 3.09454011 |
5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.83744166 |
6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.54103626 |
7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.40958144 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.34063131 |
9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.23293851 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.20328278 |
11 | Lysosome_Homo sapiens_hsa04142 | 2.15488765 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 2.08207523 |
13 | RNA polymerase_Homo sapiens_hsa03020 | 2.07571826 |
14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.07297774 |
15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01831172 |
16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.95756589 |
17 | DNA replication_Homo sapiens_hsa03030 | 1.95672537 |
18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.74389712 |
19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.70009451 |
20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69482935 |
21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.68362935 |
22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64015172 |
23 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.63268384 |
24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63156555 |
25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.62911551 |
26 | RNA transport_Homo sapiens_hsa03013 | 1.45225087 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44512068 |
28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42763136 |
29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.41796557 |
30 | Homologous recombination_Homo sapiens_hsa03440 | 1.41159188 |
31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38111385 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.36974817 |
33 | Base excision repair_Homo sapiens_hsa03410 | 1.34925066 |
34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33055453 |
35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29047841 |
36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.28972037 |
37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.28913967 |
38 | Legionellosis_Homo sapiens_hsa05134 | 1.28699801 |
39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.28224331 |
40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26493311 |
41 | Insulin resistance_Homo sapiens_hsa04931 | 1.26127035 |
42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.24900108 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22077713 |
44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.21997059 |
45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19171427 |
46 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18133842 |
47 | Spliceosome_Homo sapiens_hsa03040 | 1.17947216 |
48 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17121396 |
49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16444823 |
50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15924531 |
51 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15364993 |
52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13089806 |
53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12360891 |
54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12301217 |
55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.11558826 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10084674 |
57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09804996 |
58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07803133 |
59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07182329 |
60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05317312 |
61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05007876 |
62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03664570 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02667900 |
64 | Prion diseases_Homo sapiens_hsa05020 | 1.01782646 |
65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98028549 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96131448 |
67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95301582 |
68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94563141 |
69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94126776 |
70 | Cell cycle_Homo sapiens_hsa04110 | 0.93214490 |
71 | Purine metabolism_Homo sapiens_hsa00230 | 0.91175763 |
72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89588030 |
73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87652213 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86306276 |
75 | Basal transcription factors_Homo sapiens_hsa03022 | 0.86279867 |
76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85488677 |
77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85009823 |
78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83846834 |
79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81666963 |
80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81518374 |
81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81108291 |
82 | Peroxisome_Homo sapiens_hsa04146 | 0.80894363 |
83 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80013478 |
84 | ABC transporters_Homo sapiens_hsa02010 | 0.79677152 |
85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79252509 |
86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78786369 |
87 | Pertussis_Homo sapiens_hsa05133 | 0.78456571 |
88 | RNA degradation_Homo sapiens_hsa03018 | 0.77825682 |
89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77602702 |
90 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76246871 |
91 | Phagosome_Homo sapiens_hsa04145 | 0.76246793 |
92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.76205088 |
93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74729721 |
94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73974060 |
95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71909738 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71058925 |
97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70771499 |
98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70313942 |
99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70210458 |
100 | Bile secretion_Homo sapiens_hsa04976 | 0.69837968 |
101 | Shigellosis_Homo sapiens_hsa05131 | 0.69660363 |
102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68556937 |
103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66566923 |
104 | Tuberculosis_Homo sapiens_hsa05152 | 0.63922197 |
105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63185965 |
106 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.61520296 |
107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61456528 |
108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59896530 |
109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58074907 |
110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57626491 |
111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.56444135 |
112 | Insulin secretion_Homo sapiens_hsa04911 | 0.56295309 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.56113541 |
114 | Amoebiasis_Homo sapiens_hsa05146 | 0.56006391 |
115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55428454 |
116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.55001154 |
117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54853707 |
118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54778700 |
119 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.53920067 |
120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52786919 |
121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52564436 |
122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52208697 |
123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51989697 |
124 | Focal adhesion_Homo sapiens_hsa04510 | 0.51357579 |
125 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51311652 |
126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50653397 |
127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50444945 |
128 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47890446 |
129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47574889 |
130 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46943764 |
131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46885799 |
132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46499314 |
133 | Apoptosis_Homo sapiens_hsa04210 | 0.46250883 |
134 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45929764 |
135 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45606730 |
136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45078540 |
137 | Lysine degradation_Homo sapiens_hsa00310 | 0.44653988 |
138 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44269444 |
139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43814361 |
140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42758722 |
141 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.41360481 |
142 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40167044 |
143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40076885 |
144 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40005545 |
145 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39793844 |
146 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39645160 |
147 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39496145 |
148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39431716 |
149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39419933 |
150 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38733457 |
151 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38019025 |
152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35289296 |
153 | Mineral absorption_Homo sapiens_hsa04978 | 0.32288044 |
154 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29844715 |